Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration.

Mamta Singla, Yu Xin Wang, Elena Monti, Yudhishtar Bedi, Pranay Agarwal, Shiqi Su, Sara Ancel, Maiko Hermsmeier, Nitya Devisetti, Akshay Pandey, Mohsen Afshar Bakooshli, Adelaida R Palla, Stuart Goodman, Helen M Blau, Nidhi Bhutani

Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA.Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA. · pubmed

Paper

Abstract

Aging or injury to the joints can lead to cartilage degeneration and osteoarthritis (OA), for which there are limited effective treatments. We found that expression of 15-hydroxy prostaglandin dehydrogenase (15-PGDH) is increased in the articular cartilage of aged or injured mice. Both systemic and local inhibition of 15-PGDH with a small molecule inhibitor (PGDHi) led to regeneration of articular cartilage and reduction in OA-associated pain. Using single cell RNA-sequencing and multiplexed immunofluorescence imaging of cartilage, we identified the major chondrocyte subpopulations. Inhibition of 15-PGDH decreased hypertrophic-like chondrocytes expressing 15-PGDH and increased extracellular matrix-synthesizing articular chondrocytes. Cartilage regeneration appears to occur through gene expression changes in pre-existing chondrocytes, rather than stem or progenitor cell proliferation. 15-PGDH inhibition could be a potential disease-modifying and regenerative approach for osteoarthritis.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration in osteoarthritis. The paper addresses a potential therapeutic approach to regenerate cartilage, which is a significant aspect of age-related degeneration, thus contributing to the understanding of mechanisms that could mitigate aging-related joint issues.

Author of this paper? Send a correction.